Mode
Text Size
Log in / Sign up

Carotid plaque measures predict coronary heart disease in CKD patientsA Simple Neck Ultrasound Could Spot Hidden Heart Disease in Kidney Patients

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Interpret carotid plaque measures as associations, not proven predictors, in CKD patients.

This retrospective analysis examined 377 patients with chronic kidney disease, most in stage 2, to assess whether carotid plaque measures predict coronary heart disease. Researchers used propensity score matching to create comparable groups of 114 patients each, comparing those with CHD to those without. The study evaluated carotid plaque number and maximum plaque length as predictors.

Carotid plaque number showed a significant association with CHD, with an odds ratio of 2.074 (95% CI: 1.243–3.460, p = 0.005). Maximum plaque length also showed a positive association with an OR of 1.165 (95% CI: 1.073–1.265), though the exact p-value was not reported. No absolute numbers were provided for these outcomes.

Safety and tolerability data were not reported in this analysis. The study's key limitation is its observational, retrospective design, which prevents causal inference despite the use of propensity score matching to control for confounders. Other limitations, funding sources, and conflicts of interest were not reported.

For clinical practice, this analysis suggests carotid plaque measures may have predictive value for CHD in CKD patients, but the retrospective nature means these findings should be interpreted cautiously as associations rather than proven predictors. The study provides no guidance on how these measures might be integrated into clinical decision-making.

A Dangerous Combination Hiding in Plain Sight

Heart disease and kidney disease are frequent companions. When the kidneys start to struggle, the heart often follows — and vice versa. Coronary heart disease (CHD) is one of the leading causes of death in people with chronic kidney disease (CKD).

The trouble is detecting it safely.

Why Diagnosing Heart Disease Gets Complicated With Kidney Problems

The standard way to look at the arteries feeding the heart involves coronary angiography or CT angiography — both of which use contrast dye injected into the bloodstream. That dye is processed by the kidneys.

In people with CKD, that dye can cause a sudden worsening of kidney function. It's called contrast-induced nephropathy, and it can push a patient from early kidney disease toward more serious, irreversible damage.

Doctors are often caught between two risks: missing dangerous heart disease, or accelerating kidney failure to find it.

How the Neck Holds a Clue to the Heart

Arteries throughout the body tend to develop plaque — fatty, calcium-laden deposits — at similar rates. The carotid arteries in the neck are easy to image with standard ultrasound, no dye required.

Think of the arterial system as a plumbing network. If the pipes in one area of the house are rusting and clogging, there's a good chance the ones in other areas are too. Carotid plaque, it turns out, may be a visible indicator of what's happening deeper in the coronary arteries.

Who Was in the Study

Researchers analyzed records from 377 patients with kidney insufficiency — most in early CKD stage 2 — seen at a hospital in China between 2020 and 2024. Among them, 144 had stable coronary heart disease confirmed on CT. After a statistical matching process to control for other risk factors, researchers compared carotid ultrasound findings between those with and without CHD.

Two features of carotid ultrasound emerged as independent predictors of coronary heart disease. Each additional plaque found in the carotid artery more than doubled the odds of CHD. And each millimeter increase in the length of the largest plaque raised the odds by about 16%.

A combined model using both features — along with other factors — performed well at distinguishing patients with CHD from those without, with an area under the curve suggesting moderate to strong discriminatory ability.

That's Not the Whole Story

But here's the catch.

Carotid ultrasound doesn't replace a direct look at the coronary arteries. It can raise a red flag and help doctors decide who needs closer monitoring or alternative cardiac testing. It's a screening signal — not a diagnosis.

What Specialists Are Thinking

The appeal of this approach lies in its simplicity. Carotid ultrasound is widely available, inexpensive, and completely safe for people with impaired kidneys. If validated, it could give nephrologists and cardiologists a way to triage kidney patients for cardiac workup without exposing them to contrast-induced harm.

If you've been diagnosed with early-stage CKD and have risk factors for heart disease — high blood pressure, diabetes, high cholesterol — ask your doctor whether a carotid ultrasound has been done or is appropriate. This isn't yet a standard step in all guidelines, but the data supporting it is growing.

A carotid ultrasound won't tell you whether you need a stent or surgery — it simply helps identify who deserves a closer cardiac look.

Limitations to Keep in Mind

This was a retrospective single-center study, meaning it looked back at existing records from one hospital. The patient population was largely in early CKD stages, so it's unclear whether these findings hold for more advanced kidney disease. Prospective, multi-center trials are needed before these measures become standard clinical tools.

Researchers plan to investigate whether tracking changes in carotid plaque over time — not just a single measurement — could provide even better prediction of cardiac events in CKD patients. If larger studies confirm these findings, carotid ultrasound could eventually become a routine part of kidney disease follow-up.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
BackgroundChronic kidney disease (CKD) is an established risk factor for coronary heart disease (CHD). Current CHD diagnostics—coronary angiography or CTA—require contrast agents that may worsen renal function or induce contrast-induced nephropathy. A non-contrast, non-invasive, and relatively accurate method is urgently needed to predict CHD in CKD patients.MethodsIn this retrospective analysis (2020.04–2024.10), patients with CKD were classified into stable CHD or non-CHD groups based on coronary CTA. Carotid ultrasound parameters were collected. Propensity score matching (PSM) controlled for confounders. Logistic regression identified CHD risk factors, and ROC analysis evaluated predictive performance.ResultsA total of 377 patients with renal insufficiency were enrolled, most of whom were in CKD stage 2. Among them, 144 patients had stable CHD. After matching, 114 patients per group were analyzed. Carotid plaque number (OR = 2.074, 95% CI: 1.243–3.460, p = 0.005) and maximum plaque length (OR = 1.165, 95% CI: 1.073–1.265, p 
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.